
|Articles|January 6, 2005
Men on androgen deprivation rarely screened for osteoporosis
Prostate cancer patients receiving androgen deprivation therapy are frequently not screened nor treated for osteoporosis, according to an article in the online edition of Cancer (Dec. 13, 2004).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












